Ra Pharmaceuticals Launches Protein-Like Drugs
May 23, 2012
May 24, 2012 | Ra Pharmaceuticals is announcing a $8.6 million tranche closing of a $27 million Series A round. The Cambridge, Mass.-based company has a technology platform to develop protein-like molecules that it calls Cyclomimetrics. The technology was licensed from Uppsala University in Sweden, and makes large molecules that can be made into pills. Xconomy